Lyndsey Hanson

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Emergency Department

Tyrosine Kinase

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer, Mustasin Rassel, Daryl Griffin, Lyndsey Hanson, Alberto Bardelli, Federica Di Nicolantonio, Simon S McDade, Christopher J Scott, Shauna Lambe, Manisha Maurya, Andreas U Lindner, Jochen H M Prehn, Jose Sousa, Chris Winnington, Melissa J LaBonte, Sarah J Ross, Sandra Van Schaeybroeck
Bcl-xL is a key mediator of apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer. Molecular cancer therapeutics (2022)
Atanu Chakraborty, Lyndsey Hanson, David Robinson, Hilary J Lewis, Sue Bickerton, Michael Davies, Radoslaw Polanski, Rebecca Whiteley, Alex Koers, James Atkinson, Tamara Baker, Ivan Del Barco Barrantes, Giovanni Ciotta, Jason G Kettle, Lukasz Magiera, Carla P Martins, Alison Peter, Eleanor M Wigmore, Zoe E Underwood, Sabina Cosulich, Michael Niedbala, Sarah J Ross
AZD4625 is a Potent and Selective Inhibitor of KRASG12C. Molecular cancer therapeutics 21 (10) (2022)